Viewing Study NCT00524069


Ignite Creation Date: 2025-12-24 @ 10:50 PM
Ignite Modification Date: 2026-01-02 @ 9:37 AM
Study NCT ID: NCT00524069
Status: WITHDRAWN
Last Update Posted: 2013-02-01
First Post: 2007-08-31
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Gemcitabine, Capecitabine, and Bevacizumab in Treating Patients With Pancreatic Cancer That Can Be Removed By Surgery
Sponsor: Roswell Park Cancer Institute
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2007-01
Start Date Type: None
Primary Completion Date: 2007-11
Primary Completion Date Type: ACTUAL
Completion Date: None
Completion Date Type: None
First Submit Date: 2007-08-31
First Submit QC Date: None
Study First Post Date: 2007-09-03
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2013-01-31
Last Update Post Date: 2013-02-01
Last Update Post Date Type: ESTIMATED